SLC6A3 and Parkinson disease: Franco et al., [68] have reported that low level exposure to organophosphates may contribute to PD through up-regulation of dopamine transporter and increased uptake of endogenous and exogenous neurotoxicants while increased levels result in apoptotic cell death.